
Romania's Antibiotice announces EUR 70 million R&D and critical drug production center
Romanian pharmaceutical company Antibiotice (BVB: ATB) plans to invest RON 376 million (approximately EUR 70 million) in a new research and development center focused on the production of critical medicines, the company announced on July 24. The project, …